Quality of life and psychological symptoms in Greek postmenopausal women: Association with hormone therapy

Gynecological Endocrinology

Volumn 22, Issue 12, 2006, Pages 660-668

  Koundi, Kalliopi L ^a   Christodoulakos, George E ^a   Lambrinoudaki, Irene V ^a,b   Zervas, Ioannis M ^a   Spyropoulou, Areti ^a   Fexi, Panagiota ^a   Sakkas, Pavlos N ^a   Soldatos, Constantinos R ^a   Creatsas, George C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Areteio Hospital ^*  (Greece)

Author keywords

Hormone therapy; Menopause; Psychological symptoms; Quality of life

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; TIBOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; GREECE; HORMONAL THERAPY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MARRIAGE; OBSESSION; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SOCIAL ASPECT; SYMPTOMATOLOGY; UNIVERSITY HOSPITAL; WELLBEING;

ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GREECE; HEALTH SURVEYS; HUMANS; LIFE STYLE; MEDROXYPROGESTERONE; MENTAL HEALTH; MIDDLE AGED; NORETHINDRONE; NORPREGNENES; POSTMENOPAUSE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SOCIAL BEHAVIOR;

EID: 33845627738     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590601010557     Document Type: Article

References (52)

1. Wiklund I. Methods of assessing the impact of climacteric complaints on quality of life. Maturitas 1998;29:41-50.
2. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-358.
3. Li C, Wilawan K, Samsioe G, Lidfeldt J, Agardh CD, Nerbrand C. Health profile of middle-aged women: The Women's Health in the Lund Area (WHILA) study. Hum Reprod 2002;17:1379-1385.
4. Li C, Borgfeldt C, Samsioe G, Lidfeldt J, Nerbrand C. Background factors influencing somatic and psychological symptoms in middle-age women with different hormonal status: a population-based study of Swedish women. Maturitas 2005;52:306-318.
5. Stewart DE, Boydell KM. Psychologic distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med. 1993;23:157-162.
6. Komesaroff PA, Kafanelis B, Black C, Cable V, Sudhir K, Daly J. Experiences at menopause of women in a non-English-speaking community: a qualitative study. Climacteric 2002;5:78-86.
7. Genazzani AR, Bernardi F, Pluchino N, Begliuomini S, Lenzi E, Casarosa E, Luisi M. Endocrinology of menopausal transition and its brain implications. CNS Spectr 2005;10: 449-457.
8. Genazzani AR, Nicolucci A, Campagnoli C, Crosignani P, Nappi C, Serra GB, Bottiglioni E, Cianci A, De Aloysio D, Donati Sarti C, et al. Progetto Donna Qualita della Vita Working Group. Assessment of the QoL in Italian menopausal women: comparison between HRT users and non-HRT users. Maturitas 2002;42:267-280.
9. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 2005;3:47.
10. Derman RJ, Dawood MY, Stone S. Quality of life during sequential hormone replacement therapy - a placebo-controlled study. Int Fertil Menopausal Stud 1995;40:73-78.
11. Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, Barrett-Connor E. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998;92:982-988.
12. Barnabei VM, Grady D, Stovall DW, Cauley JA, Lin F, Stuenkel CA, Stefanick ML, Pickar JH. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002;100:1209-1218.
13. Haines CJ, Yim SF, Chung TK, Lam CW, Lau EW, Ng MH, Chin R, Lee DT. A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women. Maturitas 2003;44:207-214.
14. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Women's Health Initiative Investigators. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854.
15. Sherwin BB. Impact of the changing hormonal milieu on psychological functioning. In: Lobo RA, editor. Treatment of the postmenopausal woman: Basic and clinical aspects. New York: Raven Press; 1994. pp 119-127.
16. Pearlstein TB. Hormones and depression: what are the facts about premenstrual syndrome, menopause and hormone replacement therapy? Am J Obstet Gynecol 1995;173:646-653.
17. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-995.
18. Cagnacci A, Volpe A, Arangino S, et al. Depression and anxiety in climacteric women: role of hormone replacement therapy. Menopause 1997;4:206-211.
19. Carranza-Lira S, Valentino-Figueroa ML. Estrogen therapy for depression in postmenopausal women. Int J Gynaecol Obstet 1999;65:35-38.
20. Paoletti AM, Floris S, Mannias M, Orru M, Crippa D, Orlandi R, Del Zompo MM, Melis GB. Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause. J Clin Endocrinol Metab 2001;86:608-612.
21. Stephens C, Ross N. The relationship between hormone replacement therapy use and psychological symptoms: no effects found in a New Zealand sample. Health Care Women Int. 2002;23:408-414.
22. Pearce J, Hawton K, Blake F. Psychological and sexual symptoms associated with menopause and the effects of hormone replacement therapy. Br J Psychiatry 1995;167: 163-173.
23. Pearce J, Hawton K, Blake F, Barlow D, Rees M, Fagg J, Keenan J. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study. J Psychosom Res 1997; 42:177-186.
24. Olson MB, Bairey Merz CN, Shaw LJ, Mankad S, Reis SE, Pohost GM, Smith KM, McGorray SP, Cornell CE, Kelsey SF. NHLBI-Sponsored WISE Study. Hormone replacement, race, and psychological health in women: a report from the NHLBI-Sponsored WISE Study. J Womens Health (Larchmt) 2004;13:325-332.
25. US Department of State, Bureau of Public Affairs. Greece. Backgr Notes Ser 1985;1-10.
26. Mavreas VG, Bebbington PE. Greeks, British Greek Cypriots and Londoners: a comparison of morbidity. Psychol Med 1988;18:433-442.
27. Marmanidis H, Holme G, Hafner RJ. Depression and somatic symptoms: a cross-cultural study. Aust N Z J Psychiatry 1994;28:274-278.
28. Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Res 1976;20:425-430.
29. Utian WH, Janata JW, Kingsberg SA, Schluchter M, Hamilton JC. The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to qualify quality of life through and beyond menopause. Menopause 2002; 9:402-410.
30. Derogatis LR. SCL-90 R (revised) version manual I, Baltimore (MD): Johns Hopkins University Press, 1977.
31. Avis NE, Assmann SF, Kravitz PA, Ganz PA, Ory M. Quality of life in diverse groups of midlife women: assessing the influence of menopause, health status and psychosocial and demographic factors. Qual Life Res 2004;13:933-946.
32. Borissova AM, Kovatcheva R, Shinkov A, Vukov M. A study of the psychological status and sexuality in middle-aged Bulgarian women: significance of the hormone replacement therapy (HRT). Maturitas 200;39:177-183.
33. Hardy R, Kuh D. Change in psychological and vasomotor symptom reporting during the menopause. Soc Sci Med 2002;55:1975-1988.
34. Papadopoulos FC, Petridou E, Argyropoulou S, Kontaxakis V, Dessypris N, Anastasiou A, Katsiardani KP, Trichopoulos D, Lyketsos C. Prevalence and correlates of depression in late life: a population based study from a rural Greek town. Int J Geriatr Psychiatry 2005;20:350-357.
35. Koukouli S, Vlachonikolis IG, Philalithis A. Sociodemographic factors and self-reported functional status: the significance of social support. BMC Health Serv Res 2002; 2:20.
36. Schneider HPG. The quality of life in the postmenopausal woman. Best Pract Res Clin Obstet Gynecol 2002;16:395-409.
37. Polit DF, LaRocco SA. Social and psychological correlates of menopausal symptoms. Psychosom Med 1980;42:335-345.
38. Schnatz PF, Banever AE, Greene JF, O'Sullivan DM. Pilot study of menopause symptoms in a clinic population. Menopause 2005;12:623-629.
39. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993;168:824-830.
40. Bech P, Munk-Jensen N, Obel EB, Ulrich LG, Eiken P, Pors Nielsen S. Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures. Psychother Psychosom 1998;67:259-265.
41. Karlberg J, Mattsson LA, Wiklund I. A quality of life perspective on who benefits from estradiol replacement therapy. Acta Obstet Gynecol Scand 1995;74:367-372.
42. Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Genazzani AR. Effects of low-dose, continuous combined estradiol and norethisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 2003;44:157-163.
43. Nielsen TF, Ravn P, Pitkin J, Christiansen C. Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study. Maturitas 2006;53:184-190.
44. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J Am Med Assoc 2002;288:321-333.
45. Genazzani AR, Monteleone P, Gambacciani M. Hormonal influence on the central nervous system. Maturitas 2002; 43(Suppl):11-17.
46. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology 1985;10:325-335.
47. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988;14:177-187.
48. Rudolph I, Palombo-Kinne E, Kirsch B, Mellinger U, Breitbarth H, Graser T. Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression. Climacteric 2004;7:301-311.
49. Miller KJ. The other side of estrogen replacement therapy: outcome study results of mood improvement in estrogen users and nonusers. Curr Psychiatry Rep 2003;5:439-444.
50. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 2004;55:406-412.
51. Androutsopoulou C, Livaditis M, Xenitidis KI, Trypsianis G, Samakouri M, Pastelmatzi A, Tzavaras N. Psychological problems in Christian and Moslem primary care patients in Greece. Int J Psychiatry Med 2002;32:285-294.
52. Argyriadou S, Melissopoulou H, Krania E, Karagiannidou A, Vlachonicolis I, Lionis C. Dementia and depression: two frequent disorders of the aged in primary health care in Greece. Fam Pract 2001;18:87-91.